View as an RSS Feed
View David Greene's Articles BY TICKER:
Digesting The GMO Food Controversy And What It Means For Your Investment Portfolio
- Monsanto (MON) and other Genetically Modified (GM) seed companies may be impacted by increased consumer awareness.
- Natural/Organic Grocers such as Whole Foods (WFM) will benefit from shift to non-GMO foods by consumers interested in their health and willing to pay for it.
- Small agriculture service companies like Verity Corp (VRTY) have a significant opportunity to grow rapidly as farmers transition to non-GMO food production.
- American Society Of Clinical Oncology Abstracts Point To Potential Profits
- 2 Promising Medical Companies Near Their Lows
- Medical Device Companies May Have Eyes On Non-Invasive Alternative Technology
- Time For Some Sunshine For Canadian Solar Shareholders
- A Fistful Of Dollars At Family Dollar Stores
- Waiting for the Other Shoe to Drop at American Superconductor
- Why Competititve Technologies Could Be Ridiculously Undervalued
- In the Logistics Industry, Does a Rising Tide Lift All Boats?
- Does Orexigen's Success at FDA Pave a Path for Other Obesity Drug Manufacturers?
- Competitive Technologies: More Frequent Sales to Come?
- Will the FDA Give Vivus More Time Before the Final Judgment on Qnexa?
- Weighty Issues With Vivus Take a Turn for the Better
- Crocs: Gaining Traction Going Into Christmas
- Competitive Technologies: Short Squeeze Coming or Another Leg Down?
- No Bleeding at Haemonetics
- Pain Relief Coming at Competitive Technologies?
- Amgen Likely to React Dramatically to Early FDA Approval of Osteoporosis Drug
- Delcath: Clinical Results for Melanoma Treatment More Than Skin Deep
- Competitive Technologies: A Game Changer in Pain Management?
- Competitive Technologies Up on Shareholder Meeting, Pending ASCO Presentation
- Competitive Technologies: Is the Pain Over?
- GenVec Is Not Just a One Trick Pony
- Cell Therapeutics: The Jury's Still Out on Pixatrone
- A Possible New Indication for Progenix's Relistor Could Revive Its Fortunes
- CTT's Pain Mangement Device Sales to Result in Positive Surprise in 10Q
- Progenics: Are the Prospects That Bad?
- Competitive Technologies: FDA-Approved Medical Device Hitting the Revenue Line
- Don't Throw Thornburg Mortgage into the Briarpatch Yet
- High Tide for SiRF Technology